Encavis

TokWise is a technology company focused on optimizing green energy portfolios through its advanced cross-functional platform. The company offers a suite of tools that includes automated energy data management, real-time position management, commercial optimization, and advanced portfolio forecasting. By leveraging these capabilities, TokWise enables its clients to make informed decisions quickly, ultimately maximizing their return on investment in the green energy sector.

Pexapark AG is a renewable energy platform based in Schlieren, Switzerland, that specializes in managing the revenue and risks associated with energy sales. Founded in 2017, the company offers a comprehensive suite of software and advisory services designed for post-subsidy renewable energy markets, including solar, wind, and hydro investments. Its flagship solution, PEXA®connect, provides clients with tools for price discovery, analytics, execution, and monitoring, facilitating the entire energy trading and sales workflow. Pexapark assists renewable energy investors in structuring power sales, executing power purchase agreements, and managing energy risks across 18 countries. The company aims to optimize energy sales and enhance the operational efficiency of its clients in the evolving renewable energy landscape.

Pexapark AG is a renewable energy platform based in Schlieren, Switzerland, that specializes in managing the revenue and risks associated with energy sales. Founded in 2017, the company offers a comprehensive suite of software and advisory services designed for post-subsidy renewable energy markets, including solar, wind, and hydro investments. Its flagship solution, PEXA®connect, provides clients with tools for price discovery, analytics, execution, and monitoring, facilitating the entire energy trading and sales workflow. Pexapark assists renewable energy investors in structuring power sales, executing power purchase agreements, and managing energy risks across 18 countries. The company aims to optimize energy sales and enhance the operational efficiency of its clients in the evolving renewable energy landscape.

Pexapark AG is a renewable energy platform based in Schlieren, Switzerland, that specializes in managing the revenue and risks associated with energy sales. Founded in 2017, the company offers a comprehensive suite of software and advisory services designed for post-subsidy renewable energy markets, including solar, wind, and hydro investments. Its flagship solution, PEXA®connect, provides clients with tools for price discovery, analytics, execution, and monitoring, facilitating the entire energy trading and sales workflow. Pexapark assists renewable energy investors in structuring power sales, executing power purchase agreements, and managing energy risks across 18 countries. The company aims to optimize energy sales and enhance the operational efficiency of its clients in the evolving renewable energy landscape.

Stern Energy is an independent operator focused exclusively on photovoltaics, providing a range of technical, management, and consulting services. The company caters to international players and organizations involved in renewable energy, offering maintenance, specialized services, commercial management, and advisory support. By delivering these services, Stern Energy aims to enhance the efficiency and effectiveness of its clients' operations while ensuring transparency and effective resolution of complex issues.

Hyglos GmbH is a German biotechnology company established in 2000, currently operating as a subsidiary of bioMérieux S.A. It specializes in the development of highly specific bacteriophage-derived proteins for improved detection and removal of harmful bacteria and their toxins, such as Lipopolysaccharides (LPS). Hyglos offers a range of products including endotoxin detection kits, endotoxin removal kits, and diagnostic tests for food safety testing, human diagnostics, and antimicrobial applications. Its customer base comprises universities, research institutes, diagnostic companies, biotech companies, food safety testing laboratories, and pharmaceutical companies worldwide. The company's technology enables the production of molecules for effective binding and lysis of bacteria, exploiting the principles of bacteriophage biology. Hyglos' products are sold through distributors globally.